Lucid Diagnostics Inc (LUCD) Company Profile & Statistics

Lucid Diagnostics Inc
LUCD
(Nasdaq - US)
Closed
0.99
-0.01 (-0.54%)
in:usd•As of: Nov 21, 2024 15:41 UTC -5
Open
1.00
High
1.02
Low
0.98

About Lucid Diagnostics Inc

CEO

Lishan Aklog

Headquarters

360 madison avenue, 25th floor

new york, ny 10017, united states

Auditor

Marcum LLP

Employees

Share Holders

256

Website

www.luciddx.com

Industry

medical specialties

Sector

health technology

Company Overview

Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. Lucid Diagnostics Inc. is based in NEW YORK.

Lucid Diagnostics Inc Statistics

Valuation Measures

Market Capitalization ²	59.02M
Enterprise Value	54.73M
Enterprise Value/EBITDA (ttm)	-1.26
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	13.54
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	-53.67%
Operating Margin (ttm)	-855.46%
Profit Margin (ttm)	-1258.36%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	115.35%
Return on Assets (ttm)	-123.54%

Income Statement

Revenue (ttm)	4.19M
Revenue Per Share (ttm)	0.08
Gross Profit (ttm)	-2.22M
EBITDA (ttm)³	-43.56M
Net Income Avi to Common (ttm)	-52.31M
Diluted EPS (ttm)	-1.14

Share Statistics

Beta (5Y Monthly)	1.41
52-Week Change	-23.49%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	55.50M
Dividend Yield	0.00%
Float ⁴	54.12M
% Held by Insiders	8.80%
% Held by Institutions	74.01%

Balance Sheet

Total Cash (mrq)	14.49M
Total Cash Per Share (mrq)	0.26
Total Debt (mrq)	10.20M
Total Debt/Equity (mrq)	160.93%
Current Ratio (mrq)	1.18%
Quick Ratio (mrq)	1.14%
Book Value Per Share (mrq)	0.12

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.68
Free Cash Flow (ytd)	-34.31M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Lucid Diagnostics Inc

Trade With A Regulated Broker